CFTR and Parkinson disease: Indeed, G3BP1 was recently described to promote proteasomal function and inhibit accumulation of ubiquitinated protein aggregates associated with Parkinson’s (α-synuclein) and Cystic Fibrosis (CFTR-ΔF508), which were induced by p62 and USP10.